Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action-Reference-Cited by-同舟云学术

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Published:2018-08 Issue:8 Volume:25 Page:862-869
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Prague Julia K.,Roberts Rachel E.,Comninos Alexander N.,Clarke Sophie,Jayasena Channa N.,Mohideen Pharis,Lin Vivian H.,Stern Theresa P.,Panay Nicholas,Hunter Myra S.,Webber Lorraine C.,Dhillo Waljit S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology,General Earth and Planetary Sciences,General Environmental Science

Reference36 articles.

1. Hot flushes;Stearns;Lancet,2002

2. Duration of menopausal vasomotor symptoms over the menopause transition;Avis;JAMA Intern Med,2015

3. MsFLASH participants’ priorities for alleviating menopausal symptoms;Carpenter;Climacteric,2015

4. Long-term hormone therapy for perimenopausal and postmenopausal women;Marjoribanks;Cochrane Database Syst Rev,2017

5. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients;Drewe;Springerplus,2015

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menopause transition and cardiovascular disease risk;Maturitas;2024-07

2. Phase II study of fezolinetant for treatment of vasomotor symptoms associated with menopause in Japan;Climacteric;2024-06-12

3. Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

4. Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms;Expert Opinion on Investigational Drugs;2024-01-02

5. Post cancer care in women with an increased risk of malignancy or previous malignancy: The use of hormone replacement therapy and alternative treatments;Best Practice & Research Clinical Endocrinology & Metabolism;2023-12